The healthcare world is witnessing a significant shift in blood sugar management with the arrival of GLP-1 transdermal devices. These patches offer a seemingly more comfortable alternative to subcutaneous administrations of GLP-1 receptor agonists, reducing the requirement of daily needle pokes.